These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 36372735)
1. The Association of Tissue Change and Treatment Success During High-intensity Focused Ultrasound Focal Therapy for Prostate Cancer. Khandwala YS; Soerensen SJC; Morisetty S; Ghanouni P; Fan RE; Vesal S; Rusu M; Sonn GA Eur Urol Focus; 2023 Jul; 9(4):584-591. PubMed ID: 36372735 [TBL] [Abstract][Full Text] [Related]
2. Prostate cancer treatment by the latest focal HIFU device with MRI/TRUS-fusion control biopsies: A prospective evaluation. von Hardenberg J; Westhoff N; Baumunk D; Hausmann D; Martini T; Marx A; Porubsky S; Schostak M; Michel MS; Ritter M Urol Oncol; 2018 Sep; 36(9):401.e1-401.e9. PubMed ID: 30093211 [TBL] [Abstract][Full Text] [Related]
3. Medium-term Oncological Efficacy and Patient-reported Outcomes After Focal High-intensity Focused Ultrasound: The FOXPRO Trial. Westhoff N; Ernst R; Kowalewski KF; Derigs F; Neuberger M; Nörenberg D; Popovic ZV; Ritter M; Stephan Michel M; von Hardenberg J Eur Urol Focus; 2023 Mar; 9(2):283-290. PubMed ID: 36344395 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of post-ablation mpMRI as a predictor of residual prostate cancer after focal high intensity focused ultrasound (HIFU) ablation. Khandwala YS; Morisetty S; Ghanouni P; Fan RE; Soerensen SJC; Rusu M; Sonn GA Urol Oncol; 2022 Nov; 40(11):489.e9-489.e17. PubMed ID: 36058811 [TBL] [Abstract][Full Text] [Related]
5. Contrast enhanced ultrasound (CEUS) with MRI image fusion for monitoring focal therapy of prostate cancer with high intensity focused ultrasound (HIFU)1. Apfelbeck M; Clevert DA; Ricke J; Stief C; Schlenker B Clin Hemorheol Microcirc; 2018; 69(1-2):93-100. PubMed ID: 29660918 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic Accuracy and Prognostic Value of Serial Prostate Multiparametric Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer. Chu CE; Cowan JE; Lonergan PE; Washington SL; Fasulo V; de la Calle CM; Shinohara K; Westphalen AC; Carroll PR Eur Urol Oncol; 2022 Oct; 5(5):537-543. PubMed ID: 33483265 [TBL] [Abstract][Full Text] [Related]
7. [HIFU therapy of localized prostate cancer using image-guided robotic HIFU Focal One]. Govorov AV; Vasilyev AO; Alaverdyan AI; Kolontarev KB; Pushkar DY Urologiia; 2023 May; (2):83-89. PubMed ID: 37401710 [TBL] [Abstract][Full Text] [Related]
8. Focal High Intensity Focused Ultrasound of Unilateral Localized Prostate Cancer: A Prospective Multicentric Hemiablation Study of 111 Patients. Rischmann P; Gelet A; Riche B; Villers A; Pasticier G; Bondil P; Jung JL; Bugel H; Petit J; Toledano H; Mallick S; Rouvière O; Rabilloud M; Tonoli-Catez H; Crouzet S Eur Urol; 2017 Feb; 71(2):267-273. PubMed ID: 27720531 [TBL] [Abstract][Full Text] [Related]
9. The utility of intraoperative contrast-enhanced ultrasound in detecting residual disease after focal HIFU for localized prostate cancer. Bacchetta F; Martins M; Regusci S; Jichlinski P; Meuwly JY; Lucca I; Valerio M Urol Oncol; 2020 Nov; 38(11):846.e1-846.e7. PubMed ID: 32532530 [TBL] [Abstract][Full Text] [Related]
10. A Pilot Study of Duan H; Ghanouni P; Daniel B; Rosenberg J; Davidzon GA; Aparici CM; Kunder C; Sonn GA; Iagaru A J Nucl Med; 2023 Apr; 64(4):592-597. PubMed ID: 36328488 [TBL] [Abstract][Full Text] [Related]
11. Prostate-specific antigen vs. magnetic resonance imaging parameters for assessing oncological outcomes after high intensity-focused ultrasound focal therapy for localized prostate cancer. Dickinson L; Ahmed HU; Hindley RG; McCartan N; Freeman A; Allen C; Emberton M; Kirkham AP Urol Oncol; 2017 Jan; 35(1):30.e9-30.e15. PubMed ID: 27663393 [TBL] [Abstract][Full Text] [Related]
12. Oncological Outcome and Value of Postoperative Magnetic Resonance Imaging after Focal High-Intensity Focused Ultrasound Therapy for Prostate Cancer. Rosenhammer B; Niessen C; Rotzinger L; Reiss J; Schnabel MJ; Burger M; Bründl J Urol Int; 2019; 103(3):270-278. PubMed ID: 31466073 [TBL] [Abstract][Full Text] [Related]
13. Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience. Reddy D; Peters M; Shah TT; van Son M; Tanaka MB; Huber PM; Lomas D; Rakauskas A; Miah S; Eldred-Evans D; Guillaumier S; Hosking-Jervis F; Engle R; Dudderidge T; Hindley RG; Emara A; Nigam R; McCartan N; Valerio M; Afzal N; Lewi H; Orczyk C; Ogden C; Shergill I; Persad R; Virdi J; Moore CM; Arya M; Winkler M; Emberton M; Ahmed HU Eur Urol; 2022 Apr; 81(4):407-413. PubMed ID: 35123819 [TBL] [Abstract][Full Text] [Related]
14. Focal therapy with high-intensity focused ultrasound for prostate cancer: 3-year outcomes from a prospective trial. Kaufmann B; Raess E; Schmid FA; Bieri U; Scherer TP; Elleisy M; Donati OF; Rupp NJ; Moch H; Gorin MA; Mortezavi A; Eberli D BJU Int; 2024 Apr; 133(4):413-424. PubMed ID: 37897088 [TBL] [Abstract][Full Text] [Related]
15. Medium-term oncological outcomes in a large cohort of men treated with either focal or hemi-ablation using high-intensity focused ultrasonography for primary localized prostate cancer. Stabile A; Orczyk C; Hosking-Jervis F; Giganti F; Arya M; Hindley RG; Dickinson L; Allen C; Punwani S; Jameson C; Freeman A; McCartan N; Montorsi F; Briganti A; Ahmed HU; Emberton M; Moore CM BJU Int; 2019 Sep; 124(3):431-440. PubMed ID: 30753756 [TBL] [Abstract][Full Text] [Related]
16. Magnetic Resonance Imaging and Targeted Biopsies Compared to Transperineal Mapping Biopsies Before Focal Ablation in Localised and Metastatic Recurrent Prostate Cancer After Radiotherapy. Shah TT; Kanthabalan A; Otieno M; Pavlou M; Omar R; Adeleke S; Giganti F; Brew-Graves C; Williams NR; Grierson J; Miah H; Emara A; Haroon A; Latifoltojar A; Sidhu H; Clemente J; Freeman A; Orczyk C; Nikapota A; Dudderidge T; Hindley RG; Virdi J; Arya M; Payne H; Mitra A; Bomanji J; Winkler M; Horan G; Moore CM; Emberton M; Punwani S; Ahmed HU Eur Urol; 2022 Jun; 81(6):598-605. PubMed ID: 35370021 [TBL] [Abstract][Full Text] [Related]
17. Focal therapy with high-intensity focused ultrasound for the localized prostate cancer for Asian based on the localization with MRI-TRUS fusion image-guided transperineal biopsy and 12-cores transperineal systematic biopsy: prospective analysis of oncological and functional outcomes. Shoji S; Hiraiwa S; Uemura K; Nitta M; Hasegawa M; Kawamura Y; Hashida K; Hasebe T; Tajiri T; Miyajima A Int J Clin Oncol; 2020 Oct; 25(10):1844-1853. PubMed ID: 32556840 [TBL] [Abstract][Full Text] [Related]
18. Focal High-intensity Focused Ultrasound Targeted Hemiablation for Unilateral Prostate Cancer: A Prospective Evaluation of Oncologic and Functional Outcomes. Feijoo ER; Sivaraman A; Barret E; Sanchez-Salas R; Galiano M; Rozet F; Prapotnich D; Cathala N; Mombet A; Cathelineau X Eur Urol; 2016 Feb; 69(2):214-20. PubMed ID: 26164416 [TBL] [Abstract][Full Text] [Related]
19. A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer. Guillaumier S; Peters M; Arya M; Afzal N; Charman S; Dudderidge T; Hosking-Jervis F; Hindley RG; Lewi H; McCartan N; Moore CM; Nigam R; Ogden C; Persad R; Shah K; van der Meulen J; Virdi J; Winkler M; Emberton M; Ahmed HU Eur Urol; 2018 Oct; 74(4):422-429. PubMed ID: 29960750 [TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance guided focused high frequency ultrasound ablation for focal therapy in prostate cancer - phase 1 trial. Ghai S; Perlis N; Lindner U; Hlasny E; Haider MA; Finelli A; Zlotta AR; Kulkarni GS; van der Kwast TH; McCluskey SA; Kucharczyk W; Trachtenberg J Eur Radiol; 2018 Oct; 28(10):4281-4287. PubMed ID: 29696431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]